Long-term outcome of patients with schizophrenia: A review

Canadian Journal of Psychiatry

Volumn 50, Issue 14, 2005, Pages 892-900

  Jobe, Thomas H ^a   Harrow, Martin ^a,b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b NONE   (United States)

Author keywords

Follow up studies; Longitudinal; Outcome; Prognostic factors; Psychotic disorders; Recovery; Resilience; Schizophrenia

Indexed keywords

COMPARATIVE STUDY; CONVALESCENCE; DISEASE COURSE; DISEASE SEVERITY; EVALUATION; FOLLOW UP; HUMAN; LONG TERM CARE; MENTAL DISEASE; MENTAL HEALTH CARE; MENTAL PATIENT; METHODOLOGY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PROGNOSIS; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SUICIDE; TIME OF DEATH; TREATMENT OUTCOME; VARIANCE;

EID: 31544447732     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370505001403     Document Type: Review

References (80)

1. Hegarty J, Baldessarini R, Tohen M, Waternaux C. One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry 1994;151:1409-16.
2. McGlashan T, Carpenter WJ, Bartko J. Issues of design and methodology in long-term follow-up studies. Schizophr Bull 1988;14:569-74.
3. Stephens J, Astrup C, Mangrum J. Prognostic factors in recovered and deteriorated schizophrenics. Am J Psychiatry 1966;122:1116 -21.
4. Stephens J, Astrup C, Mangrum J. Prognosis in schizophrenia: prognostic scales cross-validated in American and Norwegian patients. Arch Gen Psychiatry 1967;16:693-8.
5. Vaillant G. The prediction of recovery in schizophrenia. J Nerv Ment Dis 1962;135:448-57.
6. Harrison G, Hopper K, Craig T, Laska E, Siegal C, Wanderling J, and others. Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br J Psychiatry 2001;178:506-17.
7. McGlashan T. A selective review of recent North American long-term follow-up studies of schizophrenia. Schizophr Bull 1988;14:515-40.
8. Winokur G, Tsuang M. The natural history of mania, depression, and schizophrenia. Washington (DC): American Psychiatric Press; 1996.
9. Morrison J, Clancy J, Crowe R, Winokur G. The Iowa 500: I. Diagnostic validity in mania, depression, schizophrenia. Arch Gen Psychiatry 1972;27:457-61.
10. Clancy J, Tsuang M, Norton B, Winokur G. The Iowa 500: a comprehensive study of mania, depression, and schizophrenia. J Iowa Med Soc 1974;64:394-8.
11. Tsuang M, Winokur G. The Iowa 500: field work in a 35-year follow-up of depression, mania, and schizophrenia. Can Psychiatr Assoc J 1975;20:359-65.
12. Feighner J, Robins E, Guze S, Woodruff R, Winokur G, Munoz R. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 1972;26:57-63.
13. Harding C, Brooks G, Ashikiga T, Strauss J, Breier A. The Vermont longitudinal study of persons with severe mental illness, I. Methodology, study sample, and overall status 32 years later. Am J Psychiatry 1987;144:718-26.
14. Harding C, Brooks G, Ashikiga T, Strauss J, Breier A. The Vermont longitudinal study of persons with severe mental illness: II. Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. Am J Psychiatry 1987;144:727-35.
15. Strauss J, Carpenter W. The prediction of outcome in schizophrenia. I. Characteristics of outcome. Arch Gen Psychiatry 1972;27:739-46.
16. Brooks G, Deane W. The chronic mental patient in the community. Diseases of the Nervous System 1965;26:85-90.
17. Brooks G, Deane W, Laqueur P. Fifteen years of work therapy: its impact on a mental hospital and its community. Diseases of the Nervous System 1970;31(Suppl):161-5.
18. McGlashan T. The Chestnut Lodge Followup Study. I. Follow-up methodology and study sample. Arch Gen Psychiatry 1984;41:573-85.
19. McGlashan T. The Chestnut Lodge Followup Study. II. Long-term outcome of schizophrenia and the affective disorders. Arch Gen Psychiatry 1984;41:586-601.
20. Luborsky L. Clinicians' judgment of mental health: a proposed scale. Arch Gen Psychiatry 1962;7:141-4.
21. Stone M. Exploratory psychotherapy in schizophrenia-spectrum patients: a reevaluation in the light of long-term follow-up of schizophrenia and borderline patients. Bull Menninger Clin 1986;50:287-306.
22. Vaillant G. An historical review of the remitting schizophrenias. J Nerv Ment Dis 1964;138:48-56.
23. Vaillant G. A 10-year followup of remitting schizophrenics. Schizophr Bull 1978;4:78-85.
24. Stephens J, Astrup C. Prognosis in "process" and "non-process" schizophrenia. Am J Psychiatry 1963;119:945-54.
25. Stephens J, Pascal R, McHugh P. Long-term follow-up of patients hospitalized for schizophrenia, 1913 to 1940. J Nerv Ment Dis 1997;185:715-21.
26. Bland R, Parker J, Orn H. Prognosis in schizophrenia: a ten-year follow-up of first admissions. Arch Gen Psychiatry 1976;33:949-54.
27. Bland R, Orn H. Fourteen-year outcome in early schizophrenia. Acta Psychiatr Scand 1978;58:327-38.
28. Silverstein M, Harrow M. First rank symptoms in the post-acute schizophrenic: a followup study. Am J Psychiatry 1978;135:1481-6.
29. Carone J, Harrow M, Westermeyer J. Posthospital course and outcome in schizophrenia. Arch Gen Psychiatry 1991;48:247-53.
30. Sands J, Harrow M. Depression during the longitudinal course of schizophrenia. Schizophr Bull 1999;25:157-71.
31. Harrow M, Sands J, Silverstein M, Goldberg J. Course and outcome for schizophrenia vs other psychotic patients: a longitudinal study. Schizophr Bull 1997;23:287-303.
32. Harrow M, Grossman L, Herbener E, Davis E. Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders, and mood-incongruent psychotic symptoms. Br J Psychiatry 2000;177:421-6.
33. Herbener E, Harrow M. Are negative symptoms associated with functioning deficits in both schizophrenic and non-schizophrenic patients? A ten-year longitudinal analysis. Schizophr Bull 2004;30:813-25.
34. Harrow M, Grossman L, Jobe T, Herbener E. Do patients with schizophrenia ever show periods of recovery? A 15-year multi-followup study. Schizophr Bull 2005;31:723-4.
35. Harrow M, Jobe T, Grossman L, Martin E, Faull R. Do all patients with schizophrenia need antipsychotic medications continuously? A 20-year multi-followup study. Schizophr Bull 2005;31:486.
36. Westermeyer J, Harrow M, Marengo J. Risk for suicide in schizophrenic and other psychotic and nonpsychotic disorders. J Nerv Ment Dis 1991;179:259-66.
37. Kaplan K, Harrow M. Psychosis and functioning as risk factors for later suicidal activity among schizophrenia and schizoaffective patients: an interactive model. Suicide Life-Threat Behav 1999;29:10-24.
38. Racenstein J, Harrow M, Reed R, Martin E, Herbener E, Penn D. The relationship between positive symptoms and instrumental functioning in schizophrenia: a 10-year followup study. Schizophr Res 2002;56:95-103.
39. Harrow M, Lanin-Kettering I, Prosen M, Miller J. Disordered thinking in schizophrenia: intermingling and loss of set. Schizophr Bull 1983;9:354-67.
40. Harrow M, Lanin-Kettering I, Miller J. Impaired perspective and thought pathology in schizophrenic and psychotic disorders. Schizophr Bull 1989;15:605-23.
41. Harrow M, Jobe T, Herbener E, Goldberg J, Kaplan K. Thought disorder in schizophrenia: working memory and impaired context. J Nerv Ment Dis 2004;192:3-11.
42. Jobe T, Harrow M. Delusions. In: Kadzin A, editor. Encyclopedia of Psychology. New York (NY): Oxford University Press; 2000:467-9.
43. Harrow M, Quinlan D. Is disordered thinking unique to schizophrenia? Arch Gen Psychiatry 1977;34:15-21.
44. Harrow M, Grossman L, Silverstein M. Thought pathology in manic and schizophrenic patients: its occurrence at hospital admissions and seven weeks later. Arch Gen Psychiatry 1982;39:665-71.
45. Pogue-Guile F, Harrow M. Negative symptoms in schizophrenia: their longitudinal course and prognostic importance. Schizophr Bull 1985;11:427-39.
46. Herbener E, Harrow M. Longitudinal assessment of negative symptoms in schizophrenia/schizoaffective patients, other psychotic patients and depressed patients. Schizophr Bull 2001;27:527-37.
47. Harrow M, Yonan C, Sands J, Marengo J. Depression in schizophrenia: are neuroleptics akinesia or anhedonia involved? Schizophr Bull 1994;20:327-38.
48. Harrow M, Goldberg J, Grossman L, Meltzer H. Outcome in manic disorders: a naturalistic followup study. Arch Gen Psychiatry 1990;47:665-71.
49. Goldberg J, Harrow M, Grossman L. Course and outcome in bipolar affective disorders: a longitudinal followup study. Am J Psychiatry 1995;152:379-84.
50. Carpenter W, Bartko J, Strauss J. Signs and symptoms as predictors of outcome: a report from the International Pilot Study of Schizophrenia. Am J Psychiatry 1978;135:940-5.
51. Carpenter W, Strauss J. The prediction of outcome in schizophrenia IV. Eleven-year follow-up of the Washington IPSS cohort. J Nerv Ment Dis 1991;179:517-25.
52. Strauss J, Carpenter W. The prognosis of schizophrenia: rationale for a multidimensional concept. Schizophr Bull 1978;4:56-67.
53. Hawk A, Carpenter W, Strauss J. Diagnostic criteria and five-year outcome in schizophrenia: a report from the International Pilot Study of Schizophrenia. Arch Gen Psychiatry 1975;32:343-7.
54. Angst J. European long-term follow-up studies of schizophrenia. Schizophr Bull 1988;14:501-13.
55. Ciompi L. Catamnestic long-term study on the course of life and aging of schizophrenics. Schizophr Bull 1980;6:606-18.
56. Breier A, Schreiber J, Dyer J, Pickar D. National Institute of Mental Health Longitudinal Study of Chronic Schizophrenia: prognosis and predictors of outcome. Arch Gen Psychiatry 1991;48: 236-46.
57. Bleuler M. The schizophrenic disorders: long-term patient and family studies. New Haven (CT): Yale University Press; 1978.
58. DeSisto M, Harding C, McCormick R, Ashikaga T, Brooks G. The Maine and Vermont three-decade studies of serious mental illness. II. Longitudinal course comparisons. Br J Psychiatry 1995;167:338-42.
59. Hinterhuber H. Zur Katamnese der Schizophrenien. Fortshritte der Neurologie-Psychiatrie. 1973;41:527-88.
60. Huber G, Gross G, Schuettler R, Linz M. Longitudinal studies of schizophrenic patients. Schizophr Bull 1980;6:592-605.
61. Jeste D, Twamley E, Zorrilla L, Golshan S, Patterson T, Palmer B. Aging and outcome in schizophrenia. Acta Psychiatr Scand 2003;107:336-43.
62. Kulhara P. Outcome of schizophrenia: some transcultural observations with particular reverence to developing countries. Eur Arch Psychiatry Clin Neurosci 1994;244:227-35.
63. Lynge I, Jacobsen J. Schizophrenia in Greenland: a follow-up study. Acta Psychiatr Scand 1995;91:414-22.
64. Marinow A. Prognosis and outcome in schizophrenia. Int J Ment Health 1988;17:63-80.
65. Ogawa K, Miya M, Watarai A. A long-term follow-up study of schizophrenia in Japan - with special reference to the course of social adjustment. Br J Psychiatry 1987;151.
66. McGrath J. Myths and plain truths about schizophrenia epidemiology - the NAPR lecture 2004. Acta Psychiatr Scand 2005;111:4-11.
67. Weinberger D. From neuropathology to neurodevelopment. Lancet 1995;346:552-7.
68. Pantelis C, Yucel M, Wood S, McGorry P, Velakoulis D. Early and late neurodevelopmental disturbances in schizophrenia and their functional consequences. Aust N Z J Psychiatry 2003;37:399-406.
69. Bilder R, Goldman R, Volavka J. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry 2002;159:1018-28.
70. Fenton W, McGlashan T. Sustained remission in drug-free schizophrenic patients. Am J Psychiatry 1987;144:1306-9.
71. Tooth B, Kalyanasundaram V, Glover H, Momenzadah S. Factors consumers identify as important to recovery from schizophrenia. Australasian Psychiatry 2003;11:70-7.
72. Weiden P, Daniel DG. The standard of care in treating psychiatric disorders. Johns Hopkins University School of Medicine Advanced Studies in Medicine. 2005;5:S216-S239.
73. McGlashan T. Selective review of recent North American long-term follow-up studies of schizophrenia. In: Mirin S, Gossett J, editors. Psychiatric treatment: advances in outcome research. Washington (DC): American Psychiatric Association; 1991:61-105.
74. Davidson L, McGlashan T. The varied outcomes of schizophrenia. Can J Psychiatry 1997;42:34-43.
75. Engelhardt D, Rosen B, Feldman J, Engelhardt J, Cohen P. A 15-year follow-up of 646 schizophrenic outpatients. Schizophr Bull 1982;8:493-503.
76. Carpenter W, Kirkpatrick B. The heterogeneity of the long-term course of schizophrenia. Schizophr Bull 1988;14:645-52.
77. Tsuang M, Woolson R, Fleming J. Premature deaths in schixophrenia and affective disorders: an analysis of survival cures and variables affecting the shortened survival. Arch Gen Psychiatry 1980;37:979-83.
78. Tsuang M, Woolson R, Fleming J. Causes of death in schizophrenia and manic-depression. Br J Psychiatry 1980;136:239-42.
79. Carpenter WJ, Heinrichs D, Wagman A. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 1988;145:578-83.
80. Kirkpatrick B, Buchanan R, Ross D, Carpenter WJ. A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry 2001;58:165-71.